“…On the one hand, patients at low risk of mortality may not be treated to preserve “immunothrombosis” as a defence when, on the other hand, patients at high risk with patent excess thrombin and fibrin generation could benefit from available (antithrombin, soluble thrombomodulin) or ongoing (FXI and FXII inhibitors) therapies. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In addition, companies are experiencing flattened growth of developed markets, expiration of patents leading to the up-selling of less expensive generic drugs, and tight regulations enforced in mature markets. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The concept of “no reflow” (NR) refers to a state of myocardial tissue hypoperfusion in the presence of a patent epicardial coronary artery. The main mechanisms of this phenomenon are thought to be high platelet activity and much thrombus burden. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Six cases had concordant PS (Pulmonary stenosis), patent ductus arteriosus or perimembranous ventricular septal defect and were treated with balloon dilation, or closure. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Transoesophageal echocardiography (TOE) demonstrated a significant right-to-left intracardiac shunt through a patent foramen ovale (PFO); additionally severe tricuspid regurgitation was noted through a highly abnormal tricuspid valve. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…OBJECTIVES: To preclinically evaluate drug-eluting biopsy needles (patent pending WO2016118026) as a new potential way of antimicrobial prophylaxis for transrectal prostate biopsy. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Treatment groups were compared with regard to ROP, bronchopulmonary dysplasia, necrotizing enterocolitis, patent ductus arteriosus sepsis and growth between birth and 36 weeks. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Introduction: We evaluated chest pain alongside other midterm subjective and objective complications of the transcatheter closure of atrial septal defects (ASDs) and patent foramen ovales (PFOs) with various closure devices. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Current virtual fencing that uses an algorithm that is patented through CSIRO involves a collar that emits a warning audio when an animal approaches a set boundary. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Clonostachys rosea strain ACM941 is a fungal bio-control agent patented against the causative agent of Fusarium Head Blight, Fusarium graminearum. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…To solve this particular problem, the treatment plant authorities are currently evaluating an acidic chemical leaching (sulfuric or hydrochloric acid) process at a pH between 2 and 3, using an oxidizing agent such as ferric chloride or hydrogen peroxide (METIX-AC technology, patent pending; [20]). They could integrate it to a 70 tds/day granulated sludge production process. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Gain and Intake were measured daily and their values relative to BW at the point of infection were calculated over the pre-patent (days 1–4 post-infection), acute (d5–8 pi), and recovery (d9–12 pi) phases of infection to assess the impact of infection. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The analysis included prospective randomized studies that compared intraoperative silicone stent insertion (silicone group) with no application of a silicone stent (control group), in which the outcomes of interest were success rate (lacrimal passage patent check with syringing, symptom relief, or endoscopic confirmation of fluorescein dye from the opening of Hasner’s valve) and morbidities (e.g., postoperative bleeding, rhinostomy closure, granulation tissue, synechia, and eyelid problems) after certain follow-up periods (over 10 weeks). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Treatment of infected mice with benznidazole or nifurtimox was efficient to reduce patent parasitemia induced by either isolate. Nevertheless, qPCR performed at 70 dpi revealed parasite DNA in the blood of mice infected with AR-SE23C but not in BOL-FC10A infected mice. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: LMS IDEAL is implemented using a combination of patented and/or published acquisition and some novel model fitting methods required to correct confounds which result from the imaging and estimation processes, including: water-fat ambiguity; T2* relaxation; multi-peak fat modelling; main field inhomogeneity; T1 and noise bias; bipolar readout gradients; and eddy currents. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Additionally, the prevalence of experience of exposure to pre-treatment TB patents was higher among HCWs working in the TB-related departments, than among HCWs working in the TB-unrelated departments (78.8% vs. 61.9%, p<0.001). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Infants with respiratory distress syndrome, bronchopulmonary dysplasia, patent ductus arteriosus ligation, periventricular leukomalacia, and retinopathy of prematurity were more common in the compliance group. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The fiberoptic light delivery system integrated into a dual modality probe through a patented design allowed acquisition of OA images while minimizing typical artefacts associated with pulsed laser illumination of skin and the probe components in the US detection path. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The inclusion criteria were that patents were over 15 years old, had renal impairment, and had received intravenous levetiracetam treatment. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…There was preference for patent medicine dealers (PMDs) and pharmacies for malaria treatment. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso